Install
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
From Tablet to Spray: elivity® Introduces NANOBOOST Absorption Technology to Asia – Asia News Network
1+ week, 11+ hour ago (183+ words) From Tablet to Spray: elivity® Introduces NANOBOOST Absorption Technology to Asia Co-developed with German Biotech Science elivity®’s oral sprays take a different route. Delivered beneath the tongue, active compounds are absorbed directly through the mucosal tissue and into the…...
Investigational Outpatient LBP Procedure Trial Underweigh
5+ mon, 3+ week ago (18+ words) Disc therapy shows promise for chronic low back pain relief with Hydrafil improving function in degenerative disc disease....
U.S. Physical Therapy Announces $450 Million Credit Facility
4+ mon, 4+ week ago (151+ words) The credit facility syndicate consists of Bank of America Securities Inc. as Joint Lead Arranger and Sole Bookrunner with Bank of America, N.A. as Administrative Agent, and Regions Capital Markets, a division of Regions Bank, as Joint Lead Arranger and Syndication…...
Tonix Presents Positive Phase 3 RESILIENT Data On TONMYA At 2026 Non-Opioid Pain Therapeutics Summit
7+ mon, 2+ week ago (118+ words) Nasdaq January 30, 2026 — 07:55 am EST (RTTNews) - Tonix Pharmaceuticals Holding Corp. (TNXP) on Friday said it presented positive results from the Phase 3 RESILIENT study of TONMYA for fibromyalgia at the 2026 Non-Opioid Pain Therapeutics Summit on January 29 in Boston. The study showed that…...
Enlivex Announces Positive 6-Month Topline Data –Demonstrating Durable and Persistent Pain Reduction and Improved Function in Primary Age-Related Patients with Moderate to Severe Knee Osteoarthritis
9+ mon, 2+ week ago (594+ words) Nes-Ziona, Israel, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. ( Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced positive six-month efficacy data from the Phase IIa stage of its randomized, multi-country Phase I/II Allocetra™ trial (ENX-CL-05-001) in…...
Tonix Pharmaceuticals Announces U.S. Commercial Availability of TONMYA™ (cyclobenzaprine HCl sublingual tablets) as a First-in-Class Fibromyalgia Treatment
9+ mon, 3+ week ago (282+ words) TONMYA is now available by prescription and available for pharmacy ordering nationwide TONMYA is the first FDA-approved treatment for fibromyalgia in more than 15 years “For years, fibromyalgia patients have struggled with limited treatment options that often fall short. The availability…...
Tonix launches its new fibromyalgia drug in US
9+ mon, 2+ week ago (636+ words) Following its FDA approval in the summer, Tonix Pharma's fibromyalgia therapy Tonmya has been launched onto the market in the US, becoming the first new drug for the painful condition in more than 16 years. Tonmya (cyclobenzaprine HCl) is a new…...
Tonix launches new oral fibromyalgia treatment
9+ mon, 2+ week ago (221+ words) Tonmya is the first approved treatment for adults with fibromyalgia in over 15 years. It is a non-opioid analgesic that, when taken at bedtime, significantly reduces fibromyalgia pain and was generally well-tolerated in clinical trials. It is designed for rabid absorption…...
Tonix Pharma announces US commercial availability of Tonmya as a first-in-class fibromyalgia treatment
9+ mon, 3+ week ago (158+ words) Chatham, New Jersey Thursday, November 20, 2025, 17:00 Hrs [IST] Tonix Phar... Tonix Pharma announces US commercial availability of Tonmya as a first-in-class fibromyalgia treatment Tonix Pharmaceuticals Holding Corp., a fully integrated, commercial biotechnology company, announced that Tonmya (cyclobenzaprine HCl sublingual tablets) is…...
Fibromyalgia Treatment Tonmya Now Available
9+ mon, 2+ week ago (333+ words) Tonmya (cyclobenzaprine HCl sublingual tablets) is now available for the treatment of adults with fibromyalgia, according to Tonix Pharmaceuticals. Tonmya⢠(cyclobenzaprine HCl sublingual tablets) is now available for the treatment of adults with fibromyalgia, according to Tonix Pharmaceuticals Tonmya is…...